NCT01000064View on ClinicalTrials.gov

Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits

PHASE3TerminatedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

December 31, 2013

Study Completion Date

May 31, 2015

Conditions
Traumatic Brain InjuryAttention Deficit Disorder
Interventions
DRUG

Vyvanse

30 mg - 70 mg capsules taken every morning for 6 weeks.

PROCEDURE

fMRI

Brain scans (fMRI) performed at baseline, 6 week visit and 12th week visit.

DRUG

Placebo

Placebo capsules taken every morning for 6 weeks.

Trial Locations (1)

37232

Vanderbilt University, Nashville

Sponsors

Collaborators (1)

Shire
All Listed Sponsors
collaborator

Shire

INDUSTRY

lead

Vanderbilt University

OTHER